๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer

โœ Scribed by Gamal H. Eltabbakh; Jerome L. Belinson; Alexander W. Kennedy; Charles V. Biscotti; Graham Casey; Raymond R. Tubbs; Leslie E. Blumenson


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
96 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


ian carcinoma is uncertain. Previous studies have yielded conflicting results and have been hampered by small patient populations, failure to account for other


๐Ÿ“œ SIMILAR VOLUMES


Is p53 an independent prognostic factor
โœ Ashwatha Narayana; Andrew T.ย M. Vaughan; Saroo Gunaratne; Satinder Kathuria; Sco ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 472 KB ๐Ÿ‘ 2 views

were used as a control group. p53 overexpression indicating a mutated p53 gene was analyzed by immunohistochemistry using the mouse monoclonal antibody D0-7. ## RESULTS. Approximately 82% of carcinomas that recurred locally expressed p53 compared with only 29% of those with local control (P รต 0.0

Plasminogen activator inhibitor-1 is an
โœ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 103 KB ๐Ÿ‘ 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

Preoperative serum level of inhibin A is
โœ Antonio E. Frias Jr.; Honghze Li; Gary L. Keeney; Karl C. Podratz; Teresa K. Woo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

## Background: The aim of this study was to determine the prognostic significance of preoperative serum inhibin and activin levels in postmenopausal women with epithelial ovarian carcinoma (eoc) by correlating serum levels with disease parameters, including tumor stage and grade and patient age. #